Skip to main content
. 2022 Feb 15;11(2):529–543. doi: 10.1007/s40122-022-00361-5

Table 3.

Patient and operative characteristics of the studied groups (DEX group: dexmedetomidine, LIDO group: lidocaine and CONTROL group: normal saline)

Group (n) DEX (n = 24) LIDO (n = 25) CONTROL (n = 25) p value
Age (years) (mean ± SD) 45.25 ± 7.48 48.48 ± 10.89 50.16 ± 10.14 0.20
Height (cm) (mean ± SD) 163.88 ± 5.54 163.92 ± 6.58 163.56 ± 5.43 0.97
Weight (kg) (mean ± SD) 66.04 ± 10.56 67.64 ± 7.99 69.44 ± 10.00 0.47
BMI (mean ± SD) 24.55 ± 3.46 25.24 ± 3.19 26.00 ± 3.87 0.36
Surgery duration (mean ± SD) 109.17 ± 30.54 119.32 ± 48.16 118.04 ± 36.09 0.62
Type of surgery (myomectomy: hysterectomy) 13:11 13:12 13:12 0.99

Values are expressed as mean ± standard deviation (SD)

BMI body mass index, n number of patients

*Statistical significance (p < 0.05)